Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
The International Normalized Ratio is a standardized way to describe how quickly your blood forms a clot compared with a reference standard. It is calculated from the prothrombin time, a clotting test that depends on proteins made by the liver and on vitamin K. Standardization makes results comparable across different laboratories and test systems.
A blood sample is taken into a citrate tube, processed to plasma, and analyzed on a coagulation instrument. Clinicians often use this test to monitor treatment with warfarin, and to help evaluate bleeding, bruising, or liver problems.
This test helps your care team balance the benefits and risks of blood thinners like warfarin. If the result is higher than expected, you may have a greater risk of bleeding; if it is lower than expected, you may have a greater risk of forming clots. Your clinician uses this information, along with your symptoms and medical history, to adjust medication doses and plan follow‑up.
It is also ordered before some procedures, and when there are concerns about liver function, vitamin K status, malabsorption, or unexpected bleeding or bruising. While many medicines that thin the blood now do not require routine laboratory monitoring, this test remains essential for anyone treated with warfarin or when doctors need a quick snapshot of clotting through the prothrombin pathway.
A higher‑than‑expected result means your blood is taking longer to clot. Causes can include a stronger effect of warfarin than intended, interactions with other medicines, reduced vitamin K, or liver issues. A lower‑than‑expected result means your blood may clot more quickly than intended, which can occur with missed doses, increased vitamin K intake, or certain drug interactions. Your clinician may adjust your treatment, review your diet and medications, and repeat the test to confirm changes.
If you are on warfarin, try to have your blood drawn at consistent times relative to your dosing, and keep your diet and medication list as stable as you can. Seek urgent care if you have signs of serious bleeding or a possible clot. Always interpret this test with your clinician, since other lab results and your clinical situation provide important context.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Large or sudden changes in foods or supplements rich in vitamin K can shift results, since vitamin K is required to make clotting proteins.
Many medicines alter how warfarin is processed or how clotting factors work, including antibiotics, antifungals, amiodarone, and some anticonvulsants.
The liver makes clotting factors and needs bile to absorb vitamin K. Liver disease or cholestasis can increase results by lowering clotting factor levels.
Heavy or erratic alcohol intake can change how the liver handles warfarin and clotting proteins, leading to unexpected result shifts.
Fever, infections, and systemic illness can change clotting factor levels or warfarin sensitivity, temporarily affecting the result.
Underfilled citrate tubes, drawing from heparinized lines, delays to the lab, or clotted samples can produce inaccurate measurements.
Some direct oral anticoagulants and heparin can variably affect the prothrombin assay, which may make interpretation more complex.
A lupus anticoagulant or low levels of certain clotting factors, such as factor VII, can prolong the test independent of warfarin use.
References